Clinical stage drug cannabinoid and hallucinogenics organization Incannex Healthcare (ASX:IHL) has named global drug
named global drug administrative heavyweight Robert B. Clark to its board as a non chief.
Clark is a senior-level vital administrative undertakings master with over 38 years of US and worldwide administrative
involvement with a move the organization accepts is a demonstration of positive support in their business.
He worked with worldwide drug monster Pfizer (NYSE:PFE) for over 20 years and was VP of overall administrative system
VP of overall administrative system and US administrative issues at the organization.
Clark drove a group of up to 150 territorial administrative experts supporting medication improvement.
At Pfizer he drove or upheld US Food and Drug Administration (FDA) endorsement of many new meds and
addressed the organization at basic connections with FDA, and other worldwide wellbeing specialists, including